Expert consensus on neurodevelopmental outcomes in pregnancy pharmacovigilance studies

Background: Exposure in utero to certain medications can disrupt processes of fetal development, including brain development, leading to a continuum of neurodevelopmental difficulties. Recognizing the deficiency of neurodevelopmental investigations within pregnancy pharmacovigilance, an internationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bromley, R. L., Bickle Graz, M., Bluett-Duncan, M., Chambers, C., Damkier, P., Dietrich, K., Dolk, H., Grant, K., Mattson, S., Meador, K. J., Nordeng, H., Oberlander, T. F., Ornoy, A., Revet, A., Richardson, J., Rovet, J., Schuler-Faccini, L., Smearman, E., Simms, V., Vorhees, C., Wide, K., Wood, A., Yates, L., Ystrom, E., Supraja, T. A., Adams, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270323/
https://www.ncbi.nlm.nih.gov/pubmed/37332344
http://dx.doi.org/10.3389/fphar.2023.1094698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270323/
https://www.ncbi.nlm.nih.gov/pubmed/37332344
http://dx.doi.org/10.3389/fphar.2023.1094698

Ejemplares similares